Paci, Valentino
Ariani, Alarico
Celletti, Eleonora
Addimanda, Olga
Lo Gullo, Alberto
Mazzanti, Camilla
Di Penta, Myriam
Sabatini, Emanuela
Cipollone, Francesco
Santoboni, Gianluca
Angrisani, Claudio
De Simone, Massimiliano
Nucera, Valeria
Ianniello, Aurora
Vallifuoco, Giulia
Mansueto, Natalia
Andracco, Romina
Ferrero, Giulio
Caccavale, Rosalba
Paroli, Marino
Del Medico, Patrizia
Smerilli, Gianluca
Farina, Antonella
Scolieri, Palma
Bruzzese, Vincenzo
Giampietro, Cecilia
Ometto, Francesca
Vukatana, Gentiana
Trevisani, Marica
Mulè, Rita
Rossi, Elisa
Vandelli, Enrica
Bixio, Riccardo
Volpe, Alessandro
Marchetta, Antonio
Larosa, Maddalena
Camellino, Dario
Bianchi, Gerolamo
Ravagnani, Viviana
Lumetti, Federica
Molica Colella, Aldo Biagio
Franchina, Veronica
Colella, Francesco Molica
Bravi, Elena
Platè, Ilaria
Arrigoni, Eugenio
Vitetta, Rosetta
Serale, Francesca
Fiorenza, Alessia
Murgia, Davide
Rovera, Guido
Amati, Gabriele
Visalli, Elisa
Amato, Giorgio
De Lucia, Francesco
Bosco, Ylenia Dal
Foti, Roberta
Fusaro, Enrico
Ditto, Maria Chiara
Bernardi, Simone
Girelli, Francesco
Priora, Marta
Bezzi, Alessandra
Focherini, Maria Cristina
Mascella, Fabio
Becciolini, Andrea
Di Donato, Eleonora
Adorni, Giuditta
Lucchini, Gianluca
Santilli, Daniele
Gabrielli, Beatrice
Giuggioli, Dilia
Raffeiner, Bernd
Reta, Massimo
Magnani, Mirco
Idolazzi, Luca
Sandri, Gilda
Foti, Rosario
Parisi, Simone
Luchetti Gentiloni, Michele Maria https://orcid.org/0000-0001-9132-7401
Moroncini, Gianluca
Article History
Received: 22 December 2025
Accepted: 20 February 2026
First Online: 14 March 2026
Declarations
:
: Valentino Paci reports speaking and/or consulting fees from AbbVie, Eli Lilly and Johnson & Johnson. Alarico Ariani reports honoraria as a speaker and/or an advisory board member of Abbvie, Amgen, Bristol-Myers Squibb, Stava EG, Johnson and Johnson, Lilly, Novartis, and UCB Pharma. Federica Lumetti has received honoraria as an advisory board member of Amgen. Michele Maria Luchetti Gentiloni reports research support from AbbVie, speaking and/or consulting fees from AbbVie, Amgen, Eli Lilly, Johnson & Johnson, Novartis and Pfizer. Gabriele Amati reports consulting fees from Novartis. Gianluca Moroncini reports speaking and/or consulting fees from AbbVie, Johnson & Johnson, Novartis and Pfizer. Eleonora Celletti, Olga Addimanda, Alberto Lo Gullo, Camilla Mazzanti, Myriam Di Penta, Emanuela Sabatini, Francesco Cipollone, Gianluca Santoboni, Claudio Angrisani, Massimiliano De Simone, Valeria Nucera, Aurora Ianniello, Giulia Vallifuoco, Natalia Mansueto, Romina Andracco, Giulio Ferrero, Rosalba Caccavale, Marino Paroli, Patrizia Del Medico, Gianluca Smerilli, Antonella Farina, Palma Scolieri, Vincenzo Bruzzese, Cecilia Giampietro, Francesca Ometto, Gentiana Vukatana, Marica Trevisani, Rita Mulè, Elisa Rossi, Enrica Vandelli, Riccardo Bixio, Alessandro Volpe, Antonio Marchetta, Maddalena Larosa, Dario Camellino, Gerolamo Bianchi, Viviana Ravagnani, Aldo Biagio Molica Colella, Veronica Franchina, Francesco Molica Colella, Elena Bravi, Ilaria Platè, Eugenio Arrigoni, Rosetta Vitetta, Francesca Serale, Alessia Fiorenza, Davide Murgia, Guido Rovera, Elisa Visalli, Giorgio Amato, Francesco De Lucia, Ylenia Dal Bosco, Roberta Foti, Enrico Fusaro, Maria Chiara Ditto, Simone Bernardi, Francesco Girelli, Marta Priora, Alessandra Bezzi, Maria Cristina Focherini, Fabio Mascella, Andrea Becciolini, Eleonora Di Donato, Giuditta Adorni, Gianluca Lucchini, Daniele Santilli, Beatrice Gabrielli, Dilia Giuggioli, Bernd Raffeiner, Massimo Reta, Mirco Magnani, Luca Idolazzi, Gilda Sandri, Rosario Foti, Simone Parisi have nothing to disclose in relation to this work.
: The study protocol was approved by the Area Vasta Emilia Nord (AVEN) Ethics Committee, protocol code 34713, and was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice guidelines. All study centres accepted the approval of the Area Vasta Emilia Nord Ethics Committee.